Fundraising FoxAmbit Health Ventures — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Osteoboost is an FDA-cleared bone health solution designed for postmenopausal women with osteopenia.
BiotechFemTechHealthtechLongevityMedical DevicesRedwood City, US
Dr. Dan Burnett(Founder & CEO of Theranova and Osteoboost Co-Founder)Dr. Shane Mangrum(PM&R Physician and Osteoboost Co-Founder)Laura Yecies(Chief Executive Officer & President)in
BoardMichael Jaasma(Chief Scientific Officer and Osteoboost Co-Founder)inJohn Osborne(Director)
Board seatSam Goldberger· per SEC Form D
Co-investorsEsplanade VenturesBand of AngelsBerkeley Angel NetworkGolden SeedsHouston Angel NetworkIT-Farm Corporation+2 more
BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms.
AI & Machine LearningBiotechDigital HealthMedical DevicesHouston, US
Steve Wallace(Chief Operating Officer, Global Supply Chain Management)inDonna J. Edmonds(CEO)inJames V. Snider(Chief Technology Officer / Advisor)Tim Van Meter(Chief Scientific Officer)Richard Noel(Chief Product and Commercial Officer)inRobert Sledd(Director)
Co-investorsBioventures InvestorsGenoa VenturesVTC VenturesGENERAL INCEPTION
Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status.
BiotechHealthtechMedical DevicesDanbury, US
Sasha Bakhru(Founder)inSolomon Steiner(Director)Michelle Brennan(Director)Daryl Mootoo(Executive Officer)Bakhru Sasha(Executive Officer, Director)Mark Pavao(Director)
Co-investorsConnecticut Innovations
Smartlens develops wearable microfluidic devices and AI-powered platforms for remote monitoring and diagnosis of anterior segment eye diseases, particularly glaucoma.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Savas Komban(Founder)in
Co-investors3E Bioventures CapitalDevice of Tomorrow CapitalStanford University
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.